We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Omega 3 Found to Improve Behavior in Children with ADHD

By LabMedica International staff writers
Posted on 03 Nov 2014
Print article
Supplements of the fatty acids omega 3 and 6 can help children and adolescents who have a specific kind of have attention deficit hyperactivity disorder (ADHD). Moreover, these findings indicate that a customized cognitive training program can improve problem behavior in children with ADHD.

Statistics show that 3%–6% of all school age children are estimated to have attention deficit hyperactivity disorder (ADHD), which entails a difficulty controlling impulses and sitting still, temper, waiting, or being attentive for more than short periods at a time. There are various kinds of ADHD where disturbances in hyperactivity, attention, and impulsivity have varying degrees of prominence. ADHD is regularly treated with stimulant medications, which are effective for most, but do not work for everyone.

In this study, 75 children and adolescents with ADHD were given either the fatty acids omega 3 and 6 or a placebo over three months, and then they were all given omega 3/6 over three months. The study was conducted double-blind, which means that neither the researchers nor the participants were allowed to know whether they received the active capsules until afterwards.

“For the group as a whole, we did not see any major improvement, but in 35% of the children and adolescents who have the inattentive subtype of ADHD called ADD, the symptoms improved so much that we can talk about a clinically relevant improvement,” said Mats Johnson, doctoral student from the Sahlgrenska Academy at the University of Gothenburg (Sweden), The findings of the study were part of Mr. Johnson’s dissertation.

The levels of omega 3 and omega 6 were also measured in blood samples, where those who had a clear improvement of their symptoms also showed a better balance between the blood levels of these two fatty acids. The dissertation also indicated that a cognitive training technique called collaborative problem solving (CPS) can be a good option or complement in the treatment of ADHD and oppositional defiant disorder (ODD).

With this approach, the children and the family receives help in training cognitive ability and solving problematic situations. The study included 17 children, whose families received up to ten weeks of CPS sessions. The families were then asked how much the behavioral problems improved directly after the treatment as well as six months afterwards. “Our study of CPS as a treatment for ADHD and ODD is the first in Sweden. All families in our study completed the treatment, and half of them experienced a large or very large improvement of the behavioral problems,” said Mr. Johnson.

The patient group that still had severe ADHD symptoms when the CPS treatment was finished was given the chance to supplement treatment with stimulants medication. In a follow-up six months later, 81% of all of the participating families experienced a large or very large improvement.

According to Mr. Johnson, this indicates that CPS can improve problem-creating behavior in children ADHD and ODD, and that children with severe ADHD symptoms can be improved using a combination of CPS and ADHD medication.

Related Links:

Sahlgrenska Academy at the University of Gothenburg


New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Unit-Dose Packaging solution
HLX
New
LH ELISA
Luteinizing Hormone ELISA
New
Hepato Fibrosis Assays
Hepato Fibrosis Assays

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: Schematic overview of maternal biomarker discovery using cell-free RNA during pregnancy (Photo courtesy of Circulation Research (2024). DOI: 10.1161/CIRCRESAHA.124.325024)

Maternal Blood Test Identifies Congenital Heart Diseases in Fetus

Each year, around 1,000 children are born with a single ventricle heart defect (SVHD), a condition where one of the heart's lower chambers is underdeveloped, too small, or missing a valve.... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.